SEC Form 4 · accession 0000884731-16-000057
ARIAD PHARMACEUTICALS INC · ARIA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paris Panayiotopoulos
Officer — President and CEO · Director
Period of report
May 12, 2016
Accepted (ET)
May 13, 2016 · 5:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000884731
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 12, 2016 | P | 26,990 | $7.41 | A | 88,089 | D | |
| Common Stock | holding | — | — | — | 61,099 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person purchased the shares of common stock in a private transaction with the Company pursuant to the terms of his employment agreement and a related subscription agreement, as summarized in the Current Report on Form 8-K filed by the Company on December 18, 2015. The current purchase of $200,000 worth of common stock, together with a prior purchase of $300,000 of common stock on February 1, 2016, fulfills the reporting person's agreement to purchase an aggregate of $500,000 worth of common stock from the Company at market price within the first year of his employment.